/R E P E A T -- NOTICE TO THE MEDIA - The Government of Canada will hold a news conference on coronavirus disease (COVID-19), post-COVID condition, and other public health concerns (COVID-19)/
OTTAWA, ON, Dec. 13, 2022 /CNW/ - The Honourable Jean-Yves Duclos, Minister of Health, along with Government of Canada officials, will provide an update on COVID-19, post-COVID condition, and other public health concerns.
After their remarks, they will be available to take questions from journalists.
Date December 14, 2022
Time 12:30 PM (EST)
Location
The news conference will be held in person at:
Room 200, Sir John A. Macdonald Building 144 Wellington Street, Ottawa
Participation in the question and answer portion of this event is in person or via Zoom, and is for accredited members of the Press Gallery only. Media who are not members of the Press Gallery may contact [email protected] for temporary access.
A teleconference line is also available for listening to the event:
Toll-free dial-in number (Canada/US): 1-866-805-7923
Local dial-in number: 613-960-7518
Participant passcode: 7030681
NOTE: To help ensure optimal simultaneous interpretation sound quality, journalists are encouraged to use a microphone (headphones/headset) or, when possible, a landline, and to avoid using speaker mode if queuing up for questions.
Remedium Healthcare Products is proud to announce the launch of NuVeria Labs' revolutionary Sacral Silicone Dressing, now available for purchase on Amazon, bringing advanced wound care solutions directly to consumers' doorsteps.
Designed to address...
Arthrex, a global leader in minimally invasive surgical technology, has once again taken home prestigious medals for product innovation at the 37th annual Edison Awards.
"This product, along with our other innovations,...
Aligned with the trend of immersive water therapy in 2024, Baros Maldives' Serenity Spa stands out as an oasis of indulgent spa and beauty rituals, boasting a 50-year legacy of luxury. Nestled within a tranquil sanctuary amidst the lush Maldivian...
Oragenics, Inc. , a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, today announced that it received a notice (the "Notice") from the NYSE American LLC (the "NYSE American") dated April...
Building on a successful phase one in which STChealth proved that the Universal Patient Identifier (UPI)?powered by Experian Health's Universal Identity Manager (UIM) and NCPDP Standardstm?can accurately identify patients across multiple datasets in...